Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06428955 · ClinicalTrials.gov registry record · Phase 4
Evaluation of a Monofocal Intraocular Lens
A Phase 4 study of Cataract, sponsored by Carl Zeiss Meditec.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
- 4
- Study locations
NCT06428955: Recruiting Phase 4 study of Cataract, sponsored by Carl Zeiss Meditec.
NCT06428955 is a Phase 4 study of Cataract that is actively recruiting participants, run by Carl Zeiss Meditec. The registered enrollment target is 44 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (81% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06428955, a Phase 4 study of Cataract, is actively recruiting participants, sponsored by Carl Zeiss Meditec.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
- 4
- Study locations
Study Summary
The aim of this study is to investigate the 3-month visual performance of the CT LUCIA 621P IOL, a hydrophobic aspheric monofocal IOL with a non-constant aspheric optic profile in adult patients 50 years of age or older who are undergoing cataract surgery.
Primary Outcome
The primary efficacy endpoint is the proportion of patients with monocular CDVA of 20/40 or better at three months
Conditions Studied
Interventions
- DEVICE CT LUCIA 621P
Study Locations (4)
Indiana
- Price Vision Group - Indianapolis
Kentucky
- Huffman & Huffman PSC - Lexington
Pennsylvania
- The Pennsylvania State University and Penn State Health - Hershey
Alcaldia Coyoacan
- Asociación Para Evitar La Ceguera en México, I.A.P. - Mexico City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2024-06-06 |
| Est. Completion | 2024-12 |
| Phase | Phase 4 |
What NCT06428955 shows while recruiting
NCT06428955 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which CT LUCIA 621P is the first listed.
NCT06428955 reports a single indexed study location in Indiana, Kentucky, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06428955 about?
NCT06428955 is a clinical study titled "Evaluation of a Monofocal Intraocular Lens". The aim of this study is to investigate the 3-month visual performance of the CT LUCIA 621P IOL, a hydrophobic aspheric monofocal IOL with a non-constant aspheric optic profile in adult patients 50 years of age or older who are undergoing cataract surgery.
What is the current status of trial NCT06428955?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2024-06-06. Estimated completion is 2024-12.
What conditions does trial NCT06428955 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT06428955?
The interventions under investigation include: CT LUCIA 621P (DEVICE).
Who is sponsoring clinical trial NCT06428955?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06428955 being conducted?
This trial has 4 study locations across Indiana, Kentucky, Pennsylvania, Alcaldia Coyoacan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06428955's enrollment target sits among peer trials
44 63rd of 83 higher than 21 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
-
Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI